Amphastar Pharmaceuticals Inc (29A.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 06:19PM CEST. Market open.
| Previous close | 38.76 |
| Open | 37.25 |
| Bid | 38.12 x 0 |
| Ask | 38.75 x 0 |
| Day's range | 37.25 - 38.59 |
| 52-week range | 35.50 - 58.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksImplied Volatility Surging for Amphastar (AMPH) Stock Options
Investors need to pay close attention to Amphastar (AMPH) stock based on the movements in the options market lately.
- GuruFocus.com
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
Detailed Analysis of Amphastar Pharmaceuticals Inc's Q1 2024 Financial Performance
Simply Wall St.Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
Amphastar Pharmaceuticals ( NASDAQ:AMPH ) First Quarter 2024 Results Key Financial Results Revenue: US$171.8m (up 23...
© 2024 Yahoo. All rights reserved.